4//SEC Filing
FICHTHORN JOHN 4
Accession 0001493152-21-002390
CIK 0000894871other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 3:53 PM ET
Size
16.1 KB
Accession
0001493152-21-002390
Insider Transaction Report
Form 4
theMaven, Inc.MVEN
FICHTHORN JOHN
Director
Transactions
- Award
Common Stock
2020-02-06+125,000→ 392,858 total - Award
Common Stock
2019-01-01+208,333→ 267,858 total - Award
Options to purchase
2019-04-10+967,280→ 967,280 totalExercise: $0.46Exp: 2019-04-10→ Common Stock (967,280 underlying) - Award
Restricted Stock Units
2020-06-05+750,000→ 750,000 totalExercise: $0.00→ Common Stock (750,000 underlying) - Award
Common Stock
2018-09-01+59,525→ 59,525 total - Award
Common Stock
2021-01-01+166,667→ 559,525 total
Footnotes (4)
- [F1]Vesting is a combined overlay of Time-based, Stock-Price-based, and Stock-Listing-based conditions. Time-based vesting is 1/3 vest after 1 year, with the balance monthly over next 2 years. Stock-Price vesting is a potential downward adjustment to the otherwise Time-based vested shares, where such adjustment is based on the rolling 45-day Volume Weighted Average Price set against specific price targets. Stock Listing vesting means that no otherwise Time-based and Stock Price-based vested shares are actually deemed as vested unless the Issuer's common stock is listed on a national securities exchange registered with the Securities and Exchange Commission under Section 6 of the Securities Exchange Act of 1934.
- [F2]The ability to exercise is subject to both: i) vesting conditions (1) and ii) the Issuer's Board of Directors approving a requisite increase in authorized shares of common stock, after the date the grant was issued, that would apply to this grant
- [F3]250,000 vest on 12/31/20 subject to achievement of strategic goals to be set by the Board; 250,000 vest in 6 monthly installments beginning 1/1/2021; 125,000 vest on 12/31/20 if ABG good standing (meaning that between the Date of Grant and December 31, 2020, the Issuer remains at all times in good standing with Authentic Brands Group and its affiliates ("ABG"), with "good standing" with ABG being deemed so long as no litigation is or has been initiated, or is in the view of the Board of Directors of the Issuer, imminent, between the Company and ABG); and 125,000 vest upon successful completion of the listing of the Issuer's common stock on a national securities exchange, provided that either (i) such listing is complete on or before March 31, 2021 or (ii) the Company is current in its periodic filings with the Securities and Exchange Commission by December 31, 2020;
- [F4]No RSUs may vest or be exercised prior to both (i) the date on which the Issuer duly files an amendment to its certificate of incorporation to sufficiently increase its authorized common stock to permit the settlement in full of exercise of all convertible securities outstanding, and (ii) the date on which the Issuer's board of directors and stockholders have both duly approved an increase in the requisite number of shares of common stock available under the Plan sufficient to permit the immediate settlement in full of the RSUs.
Documents
Issuer
theMaven, Inc.
CIK 0000894871
Entity typeother
Related Parties
1- filerCIK 0001411509
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 3:53 PM ET
- Size
- 16.1 KB